AlphaYouAR
Insider selling
Andrew Reardon sold $1.2M of Ligand Pharmaceuticals Inc (LGNYZ) stock
Andrew Reardon, CLO & Secretary of Ligand Pharmaceuticals Inc (LGNYZ), sold 5,000 shares of LGNYZ stock worth $1.2M, per an SEC Form 4 filed May 5, 2026.
The sale was pre-arranged (a 10b5-1 plan or an option exercise), not a fresh decision.
The trade happened on May 1, 2026, 4 days before it was made public.
- Traded
- May 1, 2026
- Disclosed
- May 5, 2026
- Filing delay
- 4 days
- Role
- CLO & Secretary
- Source
- SEC Form 4
More LGNYZ insider and Congress trades
From a public SEC Form 4, linked above. Not investment advice, and not a recommendation to buy or sell.